Mirella Saliola | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants	MAYO CLINIC PROCEEDINGS	2021
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study	BRITISH JOURNAL OF HAEMATOLOGY	2020
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study	INTERNATIONAL JOURNAL OF CANCER	2020
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE	2020
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort	ATHEROSCLEROSIS	2019
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation	MAYO CLINIC PROCEEDINGS	2019
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study	INTERNAL AND EMERGENCY MEDICINE	2018
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants	INTERNATIONAL JOURNAL OF CARDIOLOGY	2018
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2018
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation	AMERICAN HEART JOURNAL	2018
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY	2017
Antiphospholipid syndrome and anticoagulation quality: A clinical challenge	ATHEROSCLEROSIS	2016
Reply to. "inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke"	INTERNATIONAL JOURNAL OF CARDIOLOGY	2016
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality"	ATHEROSCLEROSIS	2016
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease	INTERNATIONAL JOURNAL OF CARDIOLOGY	2016
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation	THROMBOSIS AND HAEMOSTASIS	2015
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking Vitamin K antagonists	EUROPACE	2015
Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation	INTERNATIONAL JOURNAL OF CARDIOLOGY	2015
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study	BMJ OPEN	2015